STOCK TITAN
  1. Home
  2. Sec-filings
  3. INBP
  4. [Form 4] INTEGRATED BIOPHARMA INC Insider Trading Activity

Director gifts 11,201,964 Integrated BioPharma (INBP) shares to LLC

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTEGRATED BIOPHARMA INC director William H. Milmoe reported large stock gifts involving entities he is associated with. On April 15, 2026, entities linked to him made bona fide gifts totaling 11,201,964 shares of Common Stock at a stated price of $0.00 per share.

One gift transferred 8,966,547 shares from CD Financial, LLC to CDDS 2.0, LLC, a Florida LLC controlled by Damon DeSantis. Another transferred 2,235,417 shares from the Carl DeSantis Revocable Trust to the same CDDS 2.0, LLC. After these gifts, Milmoe’s reported holdings were 2,374,084 shares indirectly and 138,667 shares directly of Integrated BioPharma Common Stock.

Positive

  • None.

Negative

  • None.
Insider Milmoe William H.
Role Director
Type Security Shares Price Value
Gift Common Stock 8,966,547 $0.00 --
Gift Common Stock 2,235,417 $0.00 --
Holdings After Transaction: Common Stock — 2,374,084 shares (Indirect, Trustee or Officer); Common Stock — 138,667 shares (Direct)
Footnotes (1)
  1. Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. 2. Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly. Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
Total shares gifted 11,201,964 shares Bona fide gifts of Common Stock on April 15, 2026
Gift from CD Financial, LLC 8,966,547 shares Common Stock transferred to CDDS 2.0, LLC
Gift from Revocable Trust 2,235,417 shares Common Stock transferred from Carl DeSantis Revocable Trust
Direct holdings after gifts 138,667 shares Common Stock held directly by reporting person post-transaction
Indirect holdings after gifts 2,374,084 shares Common Stock held indirectly by reporting person post-transaction
Transaction price $0.00 per share Reported price for bona fide gift transactions
bona fide gift financial
"transaction_code_description: "Bona fide gift" for both stock transfers"
Common Stock financial
"security_title: "Common Stock" for all reported transactions"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect ownership financial
"ownership_type: "indirect" with nature_of_ownership "Trustee or Officer""
Revocable Trust financial
"Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
limited liability company financial
"CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis"
A limited liability company (LLC) is a business structure that separates the owners’ personal assets from the company’s debts and legal obligations, like a protective shield that keeps personal savings and property distinct from business risk. For investors, that protection reduces personal financial exposure and often brings flexible rules for profit sharing and taxes, but it can also affect how easily interests are bought or sold and how decisions are made.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Milmoe William H.
(Last)(First)(Middle)
109 SE 5TH AVENUE
SECOND FLOOR
(Street)
DELRAY BEACH FLORIDA 33483
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
INTEGRATED BIOPHARMA INC [ INBP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/15/2026G(1)8,966,547D$02,374,084(2)ITrustee or Officer
Common Stock04/15/2026G(3)2,235,417D$0138,667D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
2. 2. Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly.
3. Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.
/s/ William H Milmoe04/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did INBP director William H. Milmoe report in this Form 4?

He reported bona fide gifts totaling 11,201,964 shares of Integrated BioPharma Common Stock on April 15, 2026. These were non-cash transfers at $0.00 per share, reflecting stock moved between entities and a trust associated with the reporting person.

How many Integrated BioPharma (INBP) shares were gifted and at what price?

A total of 11,201,964 shares of INBP Common Stock were gifted, with a reported transaction price of $0.00 per share. The Form 4 characterizes both transactions as bona fide gifts, indicating no cash consideration for these transfers.

Who received the gifted INBP shares disclosed in this Form 4?

The gifted shares went to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis. One transfer was from CD Financial, LLC, and another from the Carl DeSantis Revocable Trust, both entities associated with the reporting person.

What are William H. Milmoe’s INBP holdings after these stock gifts?

Following the reported gifts, William H. Milmoe’s Form 4 shows 2,374,084 shares of Integrated BioPharma Common Stock held indirectly and 138,667 shares held directly. These figures reflect his position immediately after the April 15, 2026 transactions.

Are the INBP Form 4 transactions open-market buys or sells?

No. Both transactions are coded G, described as bona fide gifts of Common Stock at $0.00 per share. They are non-market transfers between related entities and a trust, not open-market purchases or sales on an exchange.

What entities are involved in the INBP stock transfers reported by Milmoe?

The filing references CD Financial, LLC, the Carl DeSantis Revocable Trust, and CDDS 2.0, LLC. CDDS 2.0, LLC is described as a Florida limited liability company controlled by Damon DeSantis, which received the gifted shares.